Biowa Inc - Company Review
Biowa Inc - Company ReviewSummary
Biowa Inc (BioWa), a subsidiary of Kyowa Hakko Kirin Co Ltd (KHK), is a science and technology company that provides out licensing of therapeutic antibody technologies of KHK. The company also developes fucose free monoclonal antibodies that increase cellular cytotoxicity. Its technology include potelligent, complegent and accretamab. BioWa’s potelligent is used for ADCC enhancement of therapeutic antibodies; complegent is used for CDC enhancement of therapeutic antibodies. The company’s accretamab is a combination of potelligent and complegent. Its ADCC/CDC enhanced monoclonal antibody based therapeutics used for other biotechnology and pharmaceutical companies for developing new therapies for the treatment of cancer and other diseases. The company partners include Bristol-Meyer Squibb, Genentech, Daiichi Sankyo, Astrazeneca, and Lonza, among others. BioWa is headquartered in Princeton, New Jersey, the US.
This comprehensive company report of Biowa Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.